Artiva Biotherapeutics, Inc.
ARTV
$5.52
-$0.28-4.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.19% | 6.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.21% | 0.38% | |||
| Operating Income | 4.21% | -0.38% | |||
| Income Before Tax | 3.51% | -1.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.51% | -1.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.51% | -1.29% | |||
| EBIT | 4.21% | -0.38% | |||
| EBITDA | 4.36% | -0.30% | |||
| EPS Basic | 3.87% | -0.86% | |||
| Normalized Basic EPS | -4.84% | -0.86% | |||
| EPS Diluted | 3.87% | -0.86% | |||
| Normalized Diluted EPS | -4.84% | -0.86% | |||
| Average Basic Shares Outstanding | 0.37% | 0.42% | |||
| Average Diluted Shares Outstanding | 0.37% | 0.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||